86 related articles for article (PubMed ID: 3809968)
1. The excretion of noradrenergic metabolites, particularly MHPG, in obese children and adolescents.
Popa M; Stefănescu AM; Tache A; Dumitriu L
Endocrinologie; 1986; 24(4):271-80. PubMed ID: 3809968
[TBL] [Abstract][Full Text] [Related]
2. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1989; 27(1):29-34. PubMed ID: 2474191
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
[TBL] [Abstract][Full Text] [Related]
4. Decrease of urinary levels of adrenergic metabolites including conjugated MHPG after a short term course of diethylpropion in obese children fed a mixed, low-calorie diet.
Popa M; Stefănescu AM; Dumitriu L
Endocrinologie; 1987; 25(3):179-86. PubMed ID: 3685848
[TBL] [Abstract][Full Text] [Related]
5. Direct assay of 3-methoxy-4-hydroxy-phenylglycol (MHPG) in human saliva; a new approach in the assessment of noradrenergic function.
Stefănescu AM; Popa M; Dumitriu L
Endocrinologie; 1989; 27(2):93-6. PubMed ID: 2799243
[TBL] [Abstract][Full Text] [Related]
6. The assessment of the dopaminergic tonus by urinary determinations of homovanillic acid (HVA) and dihydroxyphenylacetic acid (DOPAC) in normal, obese and GH-deficient short children.
Popa M; Stefănescu AM; Dumitriu L; Simionescu L; Giurcăneanu M
Endocrinologie; 1988; 26(3):211-20. PubMed ID: 3212382
[TBL] [Abstract][Full Text] [Related]
7. Free 3-methoxy-4-hydroxyphenylglycol (MHPG) in human urine: metabolic routes, biochemical and clinical significance in healthy and obese children.
Stefănescu AM; Popa M; Dumitriu L
Endocrinologie; 1988; 26(2):119-25. PubMed ID: 3413439
[TBL] [Abstract][Full Text] [Related]
8. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction.
Wocial B; Januszewicz W; Chodakowska J; Feltynowski T
Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic output and clinical response in depressed women during amitriptyline therapy.
Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
Pharmacopsychiatry; 1989 Jul; 22(4):144-51. PubMed ID: 2762377
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine metabolism during heroin use.
Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
[TBL] [Abstract][Full Text] [Related]
11. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
[TBL] [Abstract][Full Text] [Related]
12. Effect of moderate exercise on urinary MHPG in depressed patients.
Beckmann H; Ebert MH; Post R; Goodwin FK
Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):351-6. PubMed ID: 504341
[TBL] [Abstract][Full Text] [Related]
13. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
Schatzberg AF; Orsulak PJ; Rosenbaum AH; Kruger ER; Schildkraut JJ; Cole JO
J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
[TBL] [Abstract][Full Text] [Related]
14. Catecholamine metabolites in spinal cord injury.
Harvey RF; Fullerton DT; Carlson IH; Klein MH; Howell T
Arch Phys Med Rehabil; 1982 Sep; 63(9):419-22. PubMed ID: 7115040
[TBL] [Abstract][Full Text] [Related]
15. [Selective study of sulfate and glucuronide conjugates of urinary MHPG in nervous depression. Peripheral and central influences].
Peyrin L; Pequignot JM; Chauplannaz G; Laurent B; Moindrot J; Aimard G
Encephale; 1985; 11(1):19-24. PubMed ID: 3996286
[TBL] [Abstract][Full Text] [Related]
16. Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites.
Maas JW
Adv Biochem Psychopharmacol; 1984; 39():45-55. PubMed ID: 6431762
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone-induced reduction of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children. Comparison with hypothyroid patients of similar age having either pituitary dwarfism or congenital myxedema.
Popa M; Stefănescu AM; Dumitriu L; Dimitriu V; Bartoc R
Endocrinologie; 1989; 27(1):35-41. PubMed ID: 2474192
[TBL] [Abstract][Full Text] [Related]
18. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
Gilardini L; Parati G; Sartorio A; Mazzilli G; Pontiggia B; Invitti C
J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228
[TBL] [Abstract][Full Text] [Related]
19. Effect of supplemental ascorbic acid in a case of torsion dystonia.
Mars H
Adv Neurol; 1976; 14():319-27. PubMed ID: 941777
[TBL] [Abstract][Full Text] [Related]
20. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
Sakuma N; Nagasaka N
ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
